Why Join Us?
Be a hero for our rare disease patients
At Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs of patients and our people is always the right thing to do. To achieve this goal, our vision is to lead the future of rare disease medicine. For us, this means going where other biopharma companies won't go - challenging the status quo and creating a new model that advances our field so more patients and caregivers can benefit from life-changing treatments. We do this by following the science, applying a novel rapid development approach, making innovative medicines at fair and reasonable prices, and creating a collaborative ecosystem to reach patients in ways that are most meaningful for them.
Our commitment and care for patients extends to our people, so culture is an essential cornerstone for Ultragenyx. We remain continuously focused on creating a supportive and inclusive environment of profound learning and growth - so employees can thrive in all areas of their lives, in and outside of work. Ultimately, we want to be an organization where we would be proud for our family, friends and children to work.
If you want to have a meaningful impact, do the best work of your career, and grow a lot, both professionally and personally, come join our team.
Position Summary:
ultradedicated - Your biggest challenges yield rare possibilities
As our Senior Manager, Regulatory Affairs CMC EMEA, you drive optimal EMEA regulatory CMC strategies for assigned products during product development and manage EMEA regulatory CMC objectives in alignment with department and corporate goals. You work closely with cross functional project teams to support product development, global clinical trials and marketing approvals, while ensuring that EMEA regulatory strategies are implemented and EMEA requirements for the assigned projects are achieved. You will initially be focusing on some of Ultragenyx marketed/pipeline programs and the respective regulatory strategies including their execution. You possess appropriate knowledge of EMEA rules, regulations, and guidance governing drugs, biologics and ATMPs (e.g. gene therapy) in late phases of development and post-marketing.
Work Model:
Flex: This role will typically require onsite work 2-3 days each week, or more depending on business needs. In many locations, the business will set certain days each week that Flex employees are required to be onsite. This is a Fixed Term Contract for an initial period of 12 months.
Responsibilities: * Lead the development of regulatory strategies and interaction with Health Authorities with a focus on the EU and Middle East (EMEA) region; provide strategic input and regulatory advice to the project teams on clinical programs and life cycle management of marketed products.
MNCJobs.ch will not be responsible for any payment made to a third-party. All Terms of Use are applicable.